Optimization and evaluation of zein nanoparticles to improve the oral delivery of glibenclamide. In vivo study using C. elegans
Keywords: Glibenclamide; Diabetes; Zein; Nanoparticles; C. elegans; SANS; Controlled release; T2DM; Type II diabetes mellitus; GB; glibenclamide; KATP; ATP-dependent potassium channels; ZN; zein; Lys; lysine; NP; nanoparticles; RSM; Response surface methodology; CC